CGB cann global limited

Ann: Appendix 4C - quarterly, page-2

  1. 1,452 Posts.
    lightbulb Created with Sketch. 382
    "During the Q1 FY perio0d Cann Global through its Research Division, MCRG, invested approximately $1.1M towards the Research on MS being undertaken by the Technion Haifa, that following the earlier success in vitro in the lab, has now seen successful mice trials which are continuing, and trials on patients being monitored by leading Israeli hospitals are also currently underway."

    Human trials of the strain that slows down MS have begun. That's fantastic news and has HUGE potential if successful!
    Human trials mean is a strong indication the drug is having a positive effect.
    Last edited by Pan head: 01/11/19
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.